- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Imexpharm Corp (IMP)
35,400.0
+200.0(+0.57%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35,400.0
35,500.0
52 wk Range
32,650.0
57,000.0
Imexpharm Corp (IMP) Technical Analysis
Assess Imexpharm Corp (IMP) technical analysis based on moving-average signals and common indicators such as RSI, MACD and CCI, ranging from strong buy to strong sell. Review the IMP signals across a customisable timeframe to decide whether the stock is a buy or sell for your personal share portfolio.
Summary:Sell
| Moving Averages: | Strong Sell | Buy: (1) | Sell: (11) |
| Technical Indicators: | Neutral | Buy: (3) | Sell: (3) |
Technical Indicators
Summary: NeutralBuy: 3Neutral: 5Sell: 3
Oct 29, 2026 12:21 GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 47.418 | Neutral | ||
| STOCH(9,6) | 48.718 | Neutral | ||
| STOCHRSI(14) | 61.417 | Buy | ||
| MACD(12,26) | -55.551 | Sell | ||
| ADX(14) | 22.896 | Neutral | ||
| Williams %R | -46.667 | Neutral | ||
| CCI(14) | -20.3166 | Neutral | ||
| ATR(14) | 194.9073 | Less Volatility | ||
| Highs/Lows(14) | 25.0000 | Buy | ||
| Ultimate Oscillator | 46.633 | Sell | ||
| ROC | 1.143 | Buy | ||
| Bull/Bear Power(13) | -51.2671 | Sell | ||
Moving Averages
Summary: Strong SellBuy: 1Sell: 11
Oct 29, 2026 12:21 GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 35,450.0 Sell | | 35,417.8 Sell | | |
| MA10 | 35,455.0 Sell | | 35,422.9 Sell | | |
| MA20 | 35,397.5 Buy | | 35,446.6 Sell | | |
| MA50 | 35,682.0 Sell | | 35,658.1 Sell | | |
| MA100 | 36,063.5 Sell | | 36,008.9 Sell | | |
| MA200 | 36,684.5 Sell | | 36,551.4 Sell | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 |
| Fibonacci | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 |
| Camarilla | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 |
| Woodie's | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 | 35,400.0 |
| DeMark's | - | - | 35,400.0 | 35,400.0 | 35,400.0 | - | - |
FAQ
Is Imexpharm Corp (IMP) a Buy or Sell, from a Technical Analysis Perspective?
Based on moving averages and other technical indicators, today's Imexpharm Corp buy/sell signal is Strong Sell.
What Do The Current Moving Averages for Imexpharm Corp (IMP) Show?
The moving averages for Imexpharm Corp show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 0 Buy signals and 12 Sell signals.
What Do Today's Technical Indicators for Imexpharm Corp Show?
The technical indicators for Imexpharm Corp are in a Strong Sell position based on daily analysis, with 1 signals on buy indicators and 8 sell signals.
What Is Imexpharm Corp (IMP)'s 14-Day RSI?
The current Relative Strength Index (RSI) of IMP over the 14-day period is 47.418, which suggests that the stock is a Neutral.
What Is Imexpharm Corp (IMP)'s MACD?
IMP's MACD (Moving Average Convergence/Divergence) is -55.551, which suggests that the stock is a Sell.
What Is Imexpharm Corp (IMP)'s 5-Day Moving Average?
IMP's 5-day moving average is 35,450.0, suggesting that the stock is a Sell.
What Is Imexpharm Corp (IMP)'s 50-Day Moving Average?
IMP's 50-day moving average is 35,682.0, suggesting that the stock is a Sell.
What Is Imexpharm Corp (IMP)'s 200-Day Moving Average?
IMP's 200-day moving average is 36,684.5, suggesting that the stock is a Sell.
What Is the Fibonacci Pivot Point Performance Value for Imexpharm Corp (IMP)?
The Fibonacci pivot point performance value for IMP is 35,400.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.